Nutrient depletion caused by Fluticasone can lead to a range of health impacts. This medication is commonly used for Inflammation.
Fluticasone may deplete important nutrients your body relies on every day. These changes often occur gradually as medications affect nutrient absorption, metabolism, or utilization. Over time, low nutrient levels can contribute to fatigue, neurological symptoms, metabolic issues, and reduced resilience. Addressing these depletions can help support long-term health while continuing necessary treatment.
Chromium is a cofactor for insulin signaling complexes; inadequate chromium status has been associated in some studies with impaired glucose tolerance and worsened glycemic control, though human data are mixed.
A systematic review and meta-analysis of chromium supplementation in type 2 diabetes suggests small improvements in fasting glucose and HbA1c in some trials, but high-quality randomized studies in prediabetes found no clear benefit, indicating that the clinical impact of chromium depletion remains uncertain.
Asbaghi O et al. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2020;161:105098.; Ali A et al. Chromium effects on glucose tolerance and insulin sensitivity in persons at risk for diabetes. Diabetes Care. 2011;34(4):712-714.; Talab AT et al. Effects of chromium picolinate supplementation on glycemic status and lipid profile in type 2 diabetes. Clin Nutr Res. 2020;9(2):97-105.
Read more about Reduced Insulin SensitivityLow chromium status has been linked observationally to dyslipidemia and features of metabolic syndrome, although causality and clinical significance remain debated.
Narrative reviews highlight associations between low chromium and metabolic derangements, yet interventional trials show heterogeneous results, suggesting that any effect of depletion is modest and context-dependent.
Anderson RA. Chromium and insulin resistance. Nutr Res Rev. 2000;13(2):267-286.; Asbaghi O et al. Effects of chromium supplementation on glycemic control in patients with type 2 diabetes. Pharmacol Res. 2020;161:105098.
Read more about Unfavorable Metabolic ProfileChronic low calcium intake impairs bone mineralization and may contribute to lower bone mineral density and increased fracture risk, especially when combined with low vitamin D.
Systematic reviews indicate that increasing calcium intake yields only modest BMD gains and limited fracture risk reduction by itself, but combined calcium and vitamin D supplementation has shown benefits in specific high-risk groups such as postmenopausal women with osteoporosis.
Tai V et al. Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ. 2015;351:h4183.; Liu Y et al. The effect of calcium supplementation in people under 35 on bone mass: a systematic review and meta-analysis. eLife. 2022;11:e79002.; Cong B, Zhang H. Effects of combined calcium and vitamin D supplementation on bone mineral density and fracture risk in postmenopausal women: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2025;26:9089.
Read more about Reduced Bone Density & FracturesMarked hypocalcemia increases neuromuscular excitability, leading to perioral tingling, paresthesias, carpopedal spasms and, in extreme cases, tetany or seizures.
Clinical endocrinology sources describe neuromuscular irritability as a classic manifestation of severe hypocalcemia due to inadequate intake, malabsorption or drug-induced changes in calcium metabolism.
Bilezikian JP. Hypocalcemia. J Clin Endocrinol Metab. 2018;103(10):3827-3839.; Khan AA et al. Diagnosis and management of hypocalcemia. Endocrinol Metab Clin North Am. 2018;47(4):753-766.
Read more about Hypocalcemic Spasms & Tetany